Outputs (205)

Virtual patient educational programme to teach counselling to clinical pharmacists: development and proof of concept (2018)
Journal Article
Richardson, C. L., Chapman, S., & White, S. (2019). Virtual patient educational programme to teach counselling to clinical pharmacists: development and proof of concept. BMJ Simulation and Technology Enhanced Learning, 5(3), 167-169. https://doi.org/10.1136/bmjstel-2018-000352

Pharmacist–patient counselling can benefit patients and optimise care, but appropriate training is required. A virtual patient (VP) tool to teach pharmacists non-vitamin K oral anticoagulant counselling was developed; the VP may be used for continuin... Read More about Virtual patient educational programme to teach counselling to clinical pharmacists: development and proof of concept.

Triggering the activation of Activin A type II receptor in human adipose stem cells towards tenogenic commitment using mechanomagnetic stimulation (2018)
Journal Article
(2018). Triggering the activation of Activin A type II receptor in human adipose stem cells towards tenogenic commitment using mechanomagnetic stimulation. Nanomedicine: Nanotechnology, Biology and Medicine, 1149-1159. https://doi.org/10.1016/j.nano.2018.02.008

Stem cell therapies hold potential to stimulate tendon regeneration and homeostasis, which is maintained in response to the native mechanical environment. Activins are members of the mechano-responsive TGF-ß superfamily that participates in the regul... Read More about Triggering the activation of Activin A type II receptor in human adipose stem cells towards tenogenic commitment using mechanomagnetic stimulation.

AZD5363 plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (PAKT): A randomised, double-blind, placebo-controlled, phase II trial (2018)
Presentation / Conference Contribution
Schmid, P., Abraham, J., Chan, S., Wheatley, D., Brunt, M., Nemsadze, G., Baird, R., Hee Park, Y., Hall, P., Perren, T., Stein, R. C., László, M., Ferrero, J.-M., Phillips, M., Conibear, J., Sarker, S.-J., Prendergast, A., Cartwright, H., Mousa, K., & Turner, N. C. (2018, June). AZD5363 plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (PAKT): A randomised, double-blind, placebo-controlled, phase II trial. Presented at 2018 ASCO Annual Meeting I, Chicago, IL, USA

Background: The PI3K/AKT signalling pathway is frequently activated in triple-negative breast cancer (TNBC). AZD5363 is a highly-selective, oral, small molecule AKT inhibitor. The PAKT trial investigated the addition of AZD5363 to paclitaxel as 1st-l... Read More about AZD5363 plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (PAKT): A randomised, double-blind, placebo-controlled, phase II trial.

An evaluation of paracetamol and ibuprofen prescribing at three high-spend GP practices in Sandwell and West Birmingham: A prescribing analysis study (2018)
Presentation / Conference Contribution
Clayton, R., Vadher, N., White, S., & Chapman, S. (2018, January). An evaluation of paracetamol and ibuprofen prescribing at three high-spend GP practices in Sandwell and West Birmingham: A prescribing analysis study. Presented at ANNUAL CONFERENCE 2018, NATIONAL COUNCIL FOR VOLUNTARY ORGANISATIONS, LONDON, UK

Background
Paracetamol and ibuprofen are readily available without prescription for relief of pain and pyrexia caused by minor, self-limiting conditions. This study was part of Sandwell and West Birmingham Clinical Commissioning Group’s approach to... Read More about An evaluation of paracetamol and ibuprofen prescribing at three high-spend GP practices in Sandwell and West Birmingham: A prescribing analysis study.

Dual Acting Polymeric Nano-Aggregates for Liver Cancer Therapy (2018)
Journal Article
Al-Shakarchi, W., Alsuraifi, A., Curtis, A., & Hoskins, C. (2018). Dual Acting Polymeric Nano-Aggregates for Liver Cancer Therapy. Pharmaceutics, https://doi.org/10.3390/pharmaceutics10020063

Liver cancer treatments are often hindered by poor drug physicochemical properties, hence there is a need for improvement in order to increase patient survival and outlook. Combination therapies have been studied in order to evaluate whether increase... Read More about Dual Acting Polymeric Nano-Aggregates for Liver Cancer Therapy.

Systematic review of the impact of breast-conserving surgery on cancer outcomes of multiple ipsilateral breast cancers. (2018)
Journal Article
Winters, Z. E., Horsnell, J., Elvers, K. T., Maxwell, A. J., Jones, L. J., Shaaban, A. M., Schmid, P., Williams, N. R., Beswick, A., Greenwood, R., Ingram, J. C., Saunders, C., Vaidya, J. S., Esserman, L., Jatoi, I., & Brunt, A. M. (2018). Systematic review of the impact of breast-conserving surgery on cancer outcomes of multiple ipsilateral breast cancers. BJS Open, 2(4), 162 - 174. https://doi.org/10.1002/bjs5.53

Background: The clinical effectiveness of treating ipsilateral multifocal (MF) and multicentric (MC) breast cancers using breast-conserving surgery (BCS) compared with the standard of mastectomy is uncertain. Inconsistencies relate to definitions, in... Read More about Systematic review of the impact of breast-conserving surgery on cancer outcomes of multiple ipsilateral breast cancers..

Evaluation of a pharmacist-led diabetes educational outreach programme (2018)
Presentation / Conference Contribution
Hin Lai, U., Patel, B., White, S., & Chapman, S. (2018, January). Evaluation of a pharmacist-led diabetes educational outreach programme. Presented at Prescribing and Research in Medicines Management (UK & Ireland), Annual Conference 2018, National Council for Voluntary Organisations, London

Background
Independent Monitoring of Prescribing Analysis Cost Trends (IMPACT) campaigns, also known as educational outreach programmes, involve pharmacists providing training programmes in GP surgeries on prescribing for particular clinical issues... Read More about Evaluation of a pharmacist-led diabetes educational outreach programme.

The Influence of Nicotinamide on Health and Disease in the Central Nervous System (2018)
Journal Article
Fricker, R., Green, E., Jenkins, S., & Griffin, S. (2018). The Influence of Nicotinamide on Health and Disease in the Central Nervous System. International Journal of Tryptophan Research, https://doi.org/10.1177/1178646918776658

Nicotinamide, the amide form of vitamin B3 (niacin), has long been associated with neuronal development, survival, and function in the central nervous system (CNS), being implicated in both neuronal death and neuroprotection. Here, we summarise a bod... Read More about The Influence of Nicotinamide on Health and Disease in the Central Nervous System.

Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial (2018)
Journal Article
Roffe. (2018). Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. Lancet, 2107-2115. https://doi.org/10.1016/S0140-6736%2818%2931033-X

Background
Tranexamic acid can prevent death due to bleeding after trauma and post-partum haemorrhage. We aimed to assess whether tranexamic acid reduces haematoma expansion and improves outcome in adults with stroke due to intracerebral haemorrhage... Read More about Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial.

Synthesis of (aminoalkyl)cycleanine analogues: cytotoxicity, cellular uptake, and apoptosis induction in ovarian cancer cells (2018)
Journal Article
Uche, F., McCullagh, J., Claridge, T., Richardson, A., & Li, W. (2018). Synthesis of (aminoalkyl)cycleanine analogues: cytotoxicity, cellular uptake, and apoptosis induction in ovarian cancer cells. Bioorganic and Medicinal Chemistry Letters, 1652-1656. https://doi.org/10.1016/j.bmcl.2018.03.038

Our previous studies demonstrated that cycleanine, a macrocyclic bisbenzylisoquinoline (BBIQ) alkaloid, showed potent anti-ovarian cancer activity via apoptosis induction. Here, we synthesized two novel (aminoalkyl) cycleanine analogues (2 and 3) thr... Read More about Synthesis of (aminoalkyl)cycleanine analogues: cytotoxicity, cellular uptake, and apoptosis induction in ovarian cancer cells.